{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:49:20Z","timestamp":1771656560002,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.surg.2016.03.031","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T18:55:38Z","timestamp":1464461738000},"page":"454-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Breast cancer biology varies by method of detection and may contribute to overdiagnosis"],"prefix":"10.1016","volume":"160","author":[{"given":"Brandon","family":"Hayse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina J.","family":"Hooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigid K.","family":"Killelea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina R.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees B.","family":"Chagpar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Lannin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2016.03.031_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-151-10-200911170-00009","article-title":"Screening for breast cancer: An update for the U.S. Preventive Services Task Force","volume":"151","author":"Nelson","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.surg.2016.03.031_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2014.1398","article-title":"A\u00a0systematic assessment of benefits and risks to guide breast cancer screening decisions","volume":"311","author":"Pace","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2016.03.031_bib3","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2016.03.031_bib4","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1200\/JCO.2009.23.2025","article-title":"High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller","volume":"27","author":"Gonzalez-Angulo","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2016.03.031_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1056\/NEJMe1512092","article-title":"Biology before anatomy in early breast cancer\u2014Precisely the point","volume":"373","author":"Hudis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2016.03.031_bib6","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A\u00a0multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2016.03.031_bib7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2016.03.031_bib8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.2009.1498","article-title":"Rethinking screening for breast cancer and prostate cancer","volume":"302","author":"Esserman","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2016.03.031_bib9","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: A prescription for change","volume":"15","author":"Esserman","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2016.03.031_bib10","doi-asserted-by":"crossref","first-page":"b2587","DOI":"10.1136\/bmj.b2587","article-title":"Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends","volume":"339","author":"Jorgensen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.surg.2016.03.031_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/0003-4819-156-7-201204030-00005","article-title":"Overdiagnosis of invasive breast cancer due to mammography screening: Results from the Norwegian screening program","volume":"156","author":"Kalager","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.surg.2016.03.031_bib12","doi-asserted-by":"crossref","first-page":"g366","DOI":"10.1136\/bmj.g366","article-title":"Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial","volume":"348","author":"Miller","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.surg.2016.03.031_bib13","first-page":"106","article-title":"A\u00a0reality check for overdiagnosis estimates associated with breast cancer screening","author":"Etzioni","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.surg.2016.03.031_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK age trial at 17 years' follow-up: A randomised controlled trial","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.surg.2016.03.031_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012082","article-title":"Overdiagnosis in mammographic screening for breast cancer in Europe: A literature review","volume":"19","author":"Puliti","year":"2012","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.surg.2016.03.031_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.12120621","article-title":"Screening US in patients with mammographically dense breasts: Initial experience with Connecticut Public Act 09-41","volume":"265","author":"Hooley","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.surg.2016.03.031_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/tbj.12003","article-title":"The Connecticut experiment: The role of ultrasound in the screening of women with dense breasts","volume":"18","author":"Weigert","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.surg.2016.03.031_bib18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2016.03.031_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.ro.2011.06.001","article-title":"Screening for breast cancer with sonography","volume":"46","author":"Carkaci","year":"2011","journal-title":"Seminars in Roentgenology"},{"key":"10.1016\/j.surg.2016.03.031_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1008320317114","article-title":"Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers","volume":"11","author":"Molino","year":"2000","journal-title":"Annals of Oncol"},{"key":"10.1016\/j.surg.2016.03.031_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djr138","article-title":"Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program","volume":"103","author":"Kirsh","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.surg.2016.03.031_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/1471-2407-12-604","article-title":"Detection methods predict differences in biology and survival in breast cancer patients","volume":"12","author":"Redondo","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.surg.2016.03.031_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2407-13-15","article-title":"Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: Results from a clinical series","volume":"13","author":"Crispo","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.surg.2016.03.031_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00432-012-1304-1","article-title":"Biological characteristics of interval cancers: A role for biomarkers in the breast cancer screening","volume":"139","author":"Caldarella","year":"2013","journal-title":"Cancer Res Clin Oncol"},{"key":"10.1016\/j.surg.2016.03.031_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-011-1748-z","article-title":"Impact of mammographic screening on the detection of good and poor prognosis breast cancers","volume":"130","author":"Esserman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.surg.2016.03.031_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-013-2830-5","article-title":"Mammographic screening detects low-risk tumor biology breast cancers","volume":"144","author":"Drukker","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.surg.2016.03.031_bib27","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2016.03.031_bib28","first-page":"648","article-title":"Counterpoint: Overdiagnosis in breast cancer screening","volume":"11","author":"Smith","year":"2014","journal-title":"JACR"},{"key":"10.1016\/j.surg.2016.03.031_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1078-0432.CCR-15-0459","article-title":"Triple-negative versus non-triple-negative breast cancers in high-risk women: Phenotype features and survival from the HIBCRIT-1 MRI-including screening study","volume":"22","author":"Podo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2016.03.031_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/M14-0692","article-title":"Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts","volume":"162","author":"Sprague","year":"2015","journal-title":"Annals Internal Med"},{"key":"10.1016\/j.surg.2016.03.031_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/L15-5061-2","article-title":"Supplemental ultrasonography screening for women with dense breasts","volume":"162","author":"Hayse","year":"2015","journal-title":"Annals Internal Med"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606016300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606016300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:23:03Z","timestamp":1536682983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606016300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0039606016300447"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2016.03.031","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer biology varies by method of detection and may contribute to overdiagnosis","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2016.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}